Hubei Biocause Pharmaceutical Co., Ltd. (SZSE:000627) agreed to acquire 60% stake in Huarui Insurance Sales Co.,Ltd. for approximately CNY 150 million on September 22, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 CNY | +1.96% | -6.73% | -26.76% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.76% | 1.42B | |
+11.60% | 78.47B | |
+6.32% | 50B | |
+6.72% | 50.03B | |
+20.63% | 46.35B | |
+13.76% | 42.36B | |
+24.78% | 39.91B | |
-1.32% | 28.8B | |
-5.24% | 28.33B | |
-15.42% | 26.27B |
- Stock Market
- Equities
- 000627 Stock
- News Hubei Biocause Pharmaceutical Co., Ltd.
- Hubei Biocause Pharmaceutical Co., Ltd. agreed to acquire 60% stake in Huarui Insurance Sales Co.,Ltd. for approximately CNY 150 million.